Who we are | Why verum

The high level of education of our staff (80% Academics/Physicians) and our cross-culture expertise makes Verum a reliable and professional partner. Having been strong and effective for decades, Verum's organization reflects modern trends and clients’ requirements for CT management and quality. 32 drug candidates achieved the authorization point in the years 2000 - 2024. 51 audits and RA inspections (incl. FDA and EMEA) had been completed by Verum staff without critical findings.

Knowing European regulatory requirements and national peculiarities give us an opportunity to complete patient-related documents and CTA preparation and submission in such a way as to avoid additional clarifications from the regulatory authorities and obtain regulatory permission in an acceptable time frame.

Verum has also long and successful experience in CT application in Caucasian region, United Kingdom and North America.

Verum has developed an excellent and proven quality control system. Verum has built a QM system driven by ISO principles focusing on the reliability of data to ensure that trials are conducted and data are generated, documented and reported in compliance with the protocol, GCP and regulatory requirements.

Verum QMS is assured through comprehensive and detailed SOPs, contemporary policies, experienced QA personnel and continuous training programs.

Based on strong knowledge of CT budgeting and understanding of project resource needs, we provide the customers with the most cost-effective and realistic project planning in order to avoid hidden and additional costs.